Cargando…
Subthreshold Nanosecond Laser, from Trials to Real-Life Clinical Practice: A Cohort Study
BACKGROUND: Age-related macular degeneration (AMD), a degenerative disorder, is a major cause of irreversible severe visual deterioration in the older Western population. Thus, treatments that resolve drusen may prove helpful in limiting the progression of AMD. The study aimed to evaluate the clinic...
Autores principales: | Chichan, Hasan, Maus, Matthias, Heindl, Ludwig M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110265/ https://www.ncbi.nlm.nih.gov/pubmed/33986589 http://dx.doi.org/10.2147/OPTH.S307671 |
Ejemplares similares
-
Real-life outcomes of subthreshold laser therapy for diabetic macular edema
por: Passos, Renato M., et al.
Publicado: (2021) -
Effects of subthreshold nanosecond laser therapy in age-related macular degeneration using artificial intelligence (STAR-AI Study)
por: Hanna, Verina, et al.
Publicado: (2021) -
Single shot laser writing with sub-nanosecond and nanosecond bursts of femtosecond pulses
por: Okhrimchuk, Andrey, et al.
Publicado: (2017) -
Diabetic Macular Edema Treated with 577-nm Subthreshold Micropulse Laser: A Real-Life, Long-Term Study
por: Frizziero, Luisa, et al.
Publicado: (2021) -
Subthreshold Micropulse Laser vs. Conventional Laser for Central Serous Chorioretinopathy: A Randomized Controlled Clinical Trial
por: Zhou, Lijun, et al.
Publicado: (2021)